Skip to main content
Clinical Trials/NCT06012006
NCT06012006
Not yet recruiting
Not Applicable

Determination of the Minimal Clinically Significant Difference (MCID) of Multidimensional Dyspnea Profile (MDP) Scores in Chronic Obstructive Pulmonary Disease (COPD) Patients During Pulmonary Rehabilitation

Assistance Publique - Hôpitaux de Paris0 sites120 target enrollmentSeptember 2024
ConditionsCOPD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
COPD
Sponsor
Assistance Publique - Hôpitaux de Paris
Enrollment
120
Primary Endpoint
sensory Borg scale
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

This study is designed to determine the individual threshold of minimal clinical change (MCID) for each component of the Multidimensional Dyspnea Profile (MDP) questionnaire in COPD patients undergoing pulmonary rehabilitation.

Detailed Description

The aim of the research is to determine the minimal clinically significant difference (MCID) in MDP scores in COPD patients after a respiratory rehabilitation course using the anchoring method : * The A1 score will be compared with the Borg Affective Dyspnea (BorgA) scale. * The sensory score will be compared with the Borg Sensory Dyspnea Scale (BorgS). * The 5 sensory items will be compared with the Borg Sensory Dyspnea scale. * The emotional score will be compared with the Borg Emotional Dyspnea Scale. * The 5 emotional items will be compared with the Borg affective dyspnea scale. The various questionnaires will be administered to patients at inclusion, after a constant work-rate cycling exercise test, and at isotime during the same cycling exercise test at the end of the pulmonary rehabilitation course. The sensitivity study will be conducted using the visual analog dyspnea scale instead of the Borg score. Finally, we will also determine the MCID using the distribution method. The MCID score will be correlated with various quality of life and physical performance scores.

Registry
clinicaltrials.gov
Start Date
September 2024
End Date
November 2025
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Gold B or D COPD patient
  • Moderate to severe obstructive ventilatory disorder (FEV1\<80%)
  • Admitted for a pulmonary rehabilitation
  • Having given free, informed and written consent

Exclusion Criteria

  • Lack of French language skills, preventing completion of questionnaires
  • Cognitive impairment preventing completion of questionnaires
  • Patient under guardianship
  • Patient not affiliated to the social security system
  • Chronic ethylism

Outcomes

Primary Outcomes

sensory Borg scale

Time Frame: at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course)

The two Borg scales will be carried out at the end of the constant work-rate cycling exercise test, taking into account the last 30 seconds.

multidimensional (MDP) questionnaire

Time Frame: at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course)

The multidimensional questionnaire measuring the sensory component of dyspnea (intensity of the 5 respiratory descriptors) and the affective component of dyspnea (immediate discomfort and intensity of emotional responses). The MDP will be carried out at the end of the constant work-rate cycling exercise test, taking into account the last 30 seconds.

affective Borg scale

Time Frame: at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course)

The two Borg scales will be carried out at the end of the constant work-rate cycling exercise test, taking into account the last 30 seconds.

Secondary Outcomes

  • Hospital Anxiety and Depression scale (HADS)(at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course))
  • Saint George Respiratory Questionnaire (SGRQ)(at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course))
  • VQ11(at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course))
  • lung function tests(at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course))
  • 6 minutes walk test(at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course))
  • mMRC (Modified Medical Research Council) dyspnea score(at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course))
  • Dyspnoea 12(at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course))
  • Affective and Sensory dyspnea visual analog scale (VAS)(at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course))
  • COPD Assessment Test (CAT) score(at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course))
  • rise chair test (optional)(at inclusion and then, up to 6 weeks (at the end of pulmonary rehabilitation course))

Similar Trials